Description
10,13-Bissidechain Paclitaxel is an impurity of the chemotherapy drug paclitaxel. It is also known as paclitaxel impurity I.
| Product Unit Size | Cost | Quantity | Stock |
|---|
10,13-Bissidechain Paclitaxel is an impurity of the chemotherapy drug paclitaxel. It is also known as paclitaxel impurity I.
| Cas No. | 2157462-42-3 |
|---|---|
| Purity | ≥90% |
| Formula | C61H62N2O16 |
| Formula Wt. | 1079.17 |
| Chemical Name | Paclitaxel 10,13-Bis Side chain |
| Synonym | Paclitaxel, 10,13-bissidechain; paclitaxel impurity I |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Nicolaou K, Yang Z, Liu J, et al. Total synthesis of taxol. Nature. 1994 Feb 17;367(6464):630-634. PMID: 7906395.
Nicolaou K, Valiulin R. Synthesis and biological evaluation of new paclitaxel analogs and discovery of potent antitumor agents. Org Biomol Chem. 2013 Jul 7;11(25):4154-4163. PMID: 23685867.
Sanchez-Munoz R, Perez-Mata E, Almagro L, et al. A novel hydroxylation step in the taxane biosynthetic pathway: a new approach to paclitaxel production by synthetic biology. Front Bioeng Biotechnol. 2020 May 13;8::410. PMID: 32528936.
Guo B, Kai G, Jin H, et al. Taxol synthesis. African J Biotechnol. 2006 Jan 2;5(1):15-20.
Wang T, Chen Y, Zhuang W, et al. Transcriptome sequencing reveals regulatory mechanisms of taxol synthesis in Taxus wallichiana var. Mairei. Int J Genomics. 2019 May 2;2019:1596895. PMID: 31192250.
Peptide, alters hormone secretion and feeding b...
AMPA positive allosteric modulator, D2, 5-HT2A,...
Mcl-1 inhibitor
p110β PI3K inhibitor.
Thienylbutyl ITC analog.
Akt inhibitor.
Polyphenol found in many plants and foods.
Smoothened agonist.
Polyene, binds ergosterol and induces membrane ...
Protein translation inhibitor, peptidyl transfe...
Nitrogen mustard, DNA alkylator.
Endogenous peptide hormone derived from POMC, i...
Atypical amino acid found in Isaria sinclairi, ...
Inhibits HCV replication
ACE inhibitor.
AhR agonist, dihydroorotate dehydrogenase inhib...
Inhibitor of EGFR, HER2, VEGFR2, and FLT3.
Cysteine protease inhibitor.
CDK9 inhibitor.
KRAS inhibitor